We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

129 hedge funds and large institutions have $477M invested in Surmodics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.32% more ownership

Funds ownership: 91.2%91.52% (+0.32%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 43

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

4% less funds holding

Funds holding: 135129 (-6)

18% less capital invested

Capital invested by funds: $578M → $477M (-$101M)

92% less call options, than puts

Call options by funds: $3K | Put options by funds: $37K

Holders
129
Holders Change
-6
Holders Change %
-4.44%
% of All Funds
2.16%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
43
Reduced
43
Closed
11
Calls
$3K
Puts
$37K
Net Calls
-$34K
Net Calls Change
+$170K

SRDX Hedge Fund Activity: Q2 2022 in Review

129 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2022, worth a combined $477M — down 18% from $578M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SRDX and 10 opened new positions — a net loss of 1 holder — while 43 trimmed existing stakes and 43 added.

The largest buyer was Soleus Capital Management, adding an estimated $3.98M. The largest seller was Acadian Asset Management, cutting an estimated $1.82M.

  • 129 institutional investors held Surmodics (SRDX) as of Q2 2022, down from 135 in Q1 2022.
  • Funds reported $477M of Surmodics stock for Q2 2022, down 18% quarter-over-quarter.
  • 10 funds opened new Surmodics positions in Q2 2022 and 11 closed out, a net change of -1 holder.
  • The largest Surmodics buyer in Q2 2022 was Soleus Capital Management, an estimated $3.98M added.
  • The largest Surmodics seller in Q2 2022 was Acadian Asset Management, an estimated $1.82M sold.

Based on aggregated 13F filings for Q2 2022.